Who Owns ANTX?

AN2 Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$4.79

+0.01 (+0.10%)

Market Cap

$131.5M

Shares Outstanding

27,402,024

Institutional Holders

37

Total Inst. Value

$19.5M

% of Float Held

88.8%

QoQ Holder Change

-14

Institutional data as of Q1 2025

New Positions

6

Closed Positions

6

Increased

7

Decreased

11

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BML Capital Management, LLC$7.8M5,749,432
2Almitas Capital LLC$1.8M1,313,111
3VANGUARD GROUP INC$1.4M1,035,947
4ADAGE CAPITAL PARTNERS GP, L.L.C.$1.4M1,000,000
5PFIZER INC$973K715,295
6Peapod Lane Capital LLCNew$790K580,853
7BANK OF NOVA SCOTIA$625K459,194
8TWO SIGMA ADVISERS, LP$605K445,004
9BANK OF MONTREAL /CAN/$574K422,077
10Aldebaran Capital, LLC$553K406,623

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold ANTX?

As of Q1 2025, 37 institutional investors report holding ANTX (AN2 Therapeutics, Inc.) in their 13F filings.

What percentage of AN2 Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 88.8% of AN2 Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most ANTX?

The largest institutional holder of ANTX is BML Capital Management, LLC with $7.8M in shares.

Are institutions buying or selling ANTX?

This quarter, 6 institutions opened new positions in ANTX and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.